Risk assessment and management in cancer genetics

Fiona Lalloo ,
Oxford University Press

13
2005
A Family with Co-existing SDHB and SDHD Mutations Causing Hereditary Paraganglioma Syndrome

Kate Sarson , Michelle McConachie , Eamonn R Maher , Soo-Mi Park
American Journal of Cancer Case Reports 1 ( 1) 21 -27

2013
Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Mia M Gaudet , Tomas Kirchhoff , Todd Green , Joseph Vijai
PLoS

2010
Clinical expert letter:: Improving the identification and management of Lynch syndrome in the UK

Kevin Monahan , Deborah Alsina , Simon Bach , James Buchanan
BMJ

2017
Germline FFPE inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relatives.

Sarah Bennett , Elizabeth Alexander , Harry Fraser , Naomi Bowers
European Journal of Human Genetics 29 ( 5) 861 -871

1
2021
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.

Magnus von Knebel Doeberitz , Elke Holinski-Feder , Stefan Aretz , Gabriela Möslein
European Journal of Cancer 148 124 -133

2021
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

Hans F A Vasen , Ignacio Blanco , Katja Aktan-Collan , Jessica P Gopie
Gut 62 ( 6) 812 -823

488
2013
Update on genetic predisposition to breast cancer.

Munaza Ahmed , Fiona Lalloo , D Gareth Evans ,
Expert Review of Anticancer Therapy 9 ( 8) 1103 -1113

11
2009
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

Amanda B Spurdle , Louise Marquart , Lesley McGuffog , Sue Healey
Cancer Epidemiology, Biomarkers & Prevention 20 ( 5) 1032 -1038

11
2011
Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report

Toni Seppälä , Kirsi Pylvänäinen , Dafydd Gareth Evans , Heikki Järvinen
Hereditary Cancer in Clinical Practice 15 ( 1) 18 -18

27
2017
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Toni T Seppälä , Aysel Ahadova , Mev Dominguez-Valentin , Finlay Macrae
Hereditary Cancer in Clinical Practice 17 ( 1) 8 -8

20
2019
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report

Mev Dominguez-Valentin , Toni T Seppälä , Julian R Sampson , Finlay Macrae
Hereditary Cancer in Clinical Practice 17 ( 1) 28

12
2019
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.

Fabio Girardi , Daniel R Barnes , Daniel Barrowdale , Debra Frost
Genetics in Medicine 20 ( 12) 1575 -1582

12
2018
Use of Cytology to Diagnose Inherited Breast Cancer

Pål Møller , Gareth Evans , Elaine Anderson , Lovise Mæhle
Disease Markers 15 206 -206

3
1999
Optimal selection of individuals for BRCA mutation testing.

D Gareth R Evans , Fiona Lalloo , Diana Eccles ,
Journal of Clinical Oncology 24 ( 20) 3311 -3311

6
2006
What does a geneticist do

Fiona Lalloo
BMJ 328 ( 7439)

2004
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status

Pal Moller , D Gareth Evans , Marta M Reis , Helen Gregory
International Journal of Cancer 121 ( 5) 1017 -1020

80
2007
Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic.

Kevin J Monahan , Anne Lincoln , James E East , Sally Benton
Gut 70 ( 3) 624 -626

2
2021
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment

Mattia CF Prosperi , Sarah L Ingham , Anthony Howell , Fiona Lalloo
BMC Medical Informatics and Decision Making 14 ( 1) 87 -87

7
2014